Chargement en cours...
Pharmacology and rationale for imatinib in the treatment of scleroderma
Systemic sclerosis (scleroderma) is a chronic, multisystem, fibrotic disease. Although the pathogenesis is not completely understood, early vascular damage leads to an inflammatory reaction and a severe fibrotic response. Therapy of systemic sclerosis is still not convincing and is mainly restricted...
Enregistré dans:
| Publié dans: | J Exp Pharmacol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4863537/ https://ncbi.nlm.nih.gov/pubmed/27186133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JEP.S26894 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|